RICHTVXNEWS
Breakthrough PTSD treatment achieves 68% remission rate in clinical trial
SCIENCEDAILY · ROCKVILLE — A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity, with a clinical trial reporting a 52% reduction in symptoms and 68% remission. Researchers believe the technology could transform PTSD care and pave the way for more precise treatments for…
- CODE
- RT-881903
- PUBLISHER
- ScienceDaily
- TOPIC
- Science
- PUBLISHED
- 23 October 2026 · 11:02 UTC
- FIRST SEEN
- 28 October 2026 · 12:19 UTC
- ORIGINAL
- https://www.sciencedaily.com/releases/2026/10/261022081309.htm
- SHA-256
- 4e0ce0e875e26e2ebe9961094653d9a4401917d5b484c5e745a72a2789e9c7de
The fingerprint is the SHA-256 of the original link, the headline and the publication time joined by “|”. Anyone can recompute it to confirm the headline and link were not changed here.
Headline and short excerpt from ScienceDaily, taken from its public news feed. The full story and its photos belong to ScienceDaily — read it at the original. RICHTVX NEWS is an independent aggregator and is not affiliated with ScienceDaily. Corrections: legal@richtvx.news.